Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial.
Corboy JR, Fox RJ, Kister I, Cutter GR, Morgan CJ, Seale R, Engebretson E, Gustafson T, Miller AE; DISCOMS investigators. Corboy JR, et al. Lancet Neurol. 2023 Jul;22(7):568-577. doi: 10.1016/S1474-4422(23)00154-0. Lancet Neurol. 2023. PMID: 37353277 Clinical Trial.
Message from the Editors to our Reviewers.
Corboy JR, Powers LB, Anderson DC, Barbano RL. Corboy JR, et al. Neurol Clin Pract. 2018 Feb;8(1):2-3. doi: 10.1212/CPJ.0000000000000428. Neurol Clin Pract. 2018. PMID: 29517054 Free PMC article. No abstract available.
Real-world practice.
Corboy JR. Corboy JR. Neurol Clin Pract. 2018 Aug;8(4):275. doi: 10.1212/CPJ.0000000000000501. Neurol Clin Pract. 2018. PMID: 30140570 Free PMC article. No abstract available.
Message from the Editors to our Reviewers.
Corboy JR, Powers LB, Anderson DC, Barbano RL. Corboy JR, et al. Neurol Clin Pract. 2019 Apr;9(2):90-92. doi: 10.1212/CPJ.0000000000000616. Neurol Clin Pract. 2019. PMID: 31041121 Free PMC article. No abstract available.
Disease-modifying Therapies for Multiple Sclerosis.
Corboy JR, Goodin DS, Frohman EM. Corboy JR, et al. Curr Treat Options Neurol. 2003 Jan;5(1):35-54. doi: 10.1007/s11940-003-0021-0. Curr Treat Options Neurol. 2003. PMID: 12521562
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Frohman EM, Goodin DS, Calabresi PA, Corboy JR, Coyle PK, Filippi M, Frank JA, Galetta SL, Grossman RI, Hawker K, Kachuck NJ, Levin MC, Phillips JT, Racke MK, Rivera VM, Stuart WH; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Frohman EM, et al. Among authors: corboy jr. Neurology. 2003 Sep 9;61(5):602-11. doi: 10.1212/01.wnl.0000082654.99838.ef. Neurology. 2003. PMID: 12963748
124 results